Nasal formulation OK’d, but dosage brings fresh concerns.
Last winter, public health and harm reduction groups raised concerns about the skyrocketing price of an off-label version of nasal naloxone. Since then, two on-label formulations have been developed, and one was approved. This follow-up story looks at how the new product will play out in the real world.
See related article: FDA Comments on Nasal Naloxone Dose Concerns available at: http://www.medpagetoday.com/EmergencyMedicine/EmergencyMedicine/55440?xid=nl_mpt_DHE_2015-12-29&eun=g380369d0r
Source: MedPageToday.com – December 21 and 28, 2015